Future of Dendritic Cell–Based Approaches in Pancreatic Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Future of Dendritic Cell–Based Approaches in Pancreatic Cancer

Published:2024-09-10 Issue:26 Volume:42 Page:3067-3070
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Somasundaram Ashwin¹²,Yeh Jen Jen¹³^ORCID

Affiliation:

1. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

2. Department of Medicine, University of North Carolina, Chapel Hill, NC

3. Departments of Surgery and Pharmacology, University of North Carolina, Chapel Hill, NC

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.24.00846

Reference27 articles.

1. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

2. Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

3. Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

4. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

5. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3